LOINC
Version 2.70

97533-4Somatotropin post glucose stimulation panel - Serum or PlasmaActive

Part Description

LP422703-1   Somatotropin post glucose stimulation panel
Oral glucose inhibits the release of somatotropin, or growth hormone. In some disorders such as acromegaly, growth hormone increases in response to glucose. Measuring growth hormone after administration of glucose is used as a screening test for acromegaly and to monitor the response to treatment. Source: LOINC

Panel Hierarchy
Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
97533-4 Somatotropin post glucose stimulation panel - Serum or Plasma
Indent2963-7 Somatotropin [Mass/volume] in Serum or Plasma ng/mL
Indent55505-2 Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose glucose ng/mL
Indent55508-6 Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose glucose ng/mL
Indent55510-2 Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose ng/mL
Indent55507-8 Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose glucose ng/mL
Indent97534-2 Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose glucose ng/mL

Fully-Specified Name

Component
Somatotropin post glucose stimulation panel
Property
-
Time
Pt
System
Ser/Plas
Scale
-
Method

Additional Names

Short Name
GH p glucose Pnl SerPl
Display Name
Somatotropin post glucose stimulation panel
Consumer Name Alpha
Somatotropin post glucose stimulation panel, Blood

Basic Attributes

Class
PANEL.CHAL
Type
Laboratory
First Released
Version 2.70
Last Updated
Version 2.70
Order vs. Observation
Order
Panel Type
Panel

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=97533-4